Useful contact

– For recruitment and internship files:

– For your orders:

– To request a computer intervention:

– For missions:

– For Health and Safety questions:

– For the set-up and questions relating to a Research project:

– To report a problem with the website: 

– Website editorial committee: To propose news, events and publications to add to the website:


Heme and Iron in oxidative stress and inflammation (HIROS)

Team Gouya / Puy

Department Nephrology, Immunology and Hematology








The iron that is present in all the cells of the body, is necessary for life. It is used primarily to provide oxygen transport, electron transfer reactions, or DNA synthesis. However, the excess iron represents a real threat for the cell since it is able to generate free radicals (or “reactive oxygen species” (ROS)) during the Fenton reaction (chemical reaction, which produces from iron and oxygenated water of the hydroxyl radical: H2O2 + Fe2+®OH + OH· + Fe3+).

Iron is used mainly to produce heme, the prosthetic group of hemoproteins such as hemoglobin, myoglobin, cytochrome P450, …. In plasma, iron is bound to transferrin and its renewal is ensured on the one hand by intestinal absorption from the diet at the duodenal enterocytes (about 2 mg of iron absorbed per day) and by tissue macrophages recycling of hemoglobin, following phagocytosis of senescent red blood cells (approximately 25 mg / day). Both intestinal absorption of iron and recycling of heme-iron are controlled by hepcidin, a small peptide synthesized and secreted by the liver.

The expression of hepcidin is upregulated by iron overload and inflammation, but repressed by iron deficiency and by all the situations that stimulate erythropoiesis. The newly available hepcidin assay provides a new tool for optimizing intravenous iron treatment of anemia, particularly in inflammatory conditions.

Hepcidin is also expressed in many other organs, albeit at a much lower level. It could play a role of anti-bacterial defense.

The main pathologies linked to iron and heme metabolism disorders are: iron deficiency, hypochromic genetic microcytic anemia (sideroblastic or not), anemia of inflammation, iron overload (genetic and secondary hemochromatosis, inflammatory states), and porphyria.

Our projects allow to explore:

  • Axis 1. iron metabolism and hepcidin in the control of bacterial infections and in inflammatory conditions (deciphering the role of extrahepatic hepcidin versus hepatic hepcidin).
  • Axis 2.Pathophysiology and treatment of acute Intermittent Porphyria (AIP): oxidative stress and inflammation in resistance to heme treatment.
  • Axis 3.iron, heme and erythropoiesis in erythropoietic porphyria and genetic microcytic anemias related to abnormalities of iron metabolism.

The HIROS team brings together doctors and researchers specialized in the metabolism of heme and iron and related pathologies. Our projects are dictated in large part by our connections to the French Porphyries Center (Louis Mourier Hospital), the molecular diagnostic activity of rare microcytic anemias APHP HUPNVS (Bichat Hospital), the « Epnet » network, the laboratory of excellence GRex, and DHU Unity.

L’équipe HIROS est responsable de la plateforme Biochimie & Métabolisme ( et du dosage de l’hepcidine par spectroscopie de masse LCMSMS.


Landmark publications

  • Publication date : 24 March 2021 More

    Inherited glycosylphosphatidylinositol defects cause the rare Emm-negative blood phenotype and developmental disorders

    Autors : Romain Duval Nicolas Gaël Willemetz Alexandra Yoshiko Murakami Mahmoud Mikdar Cedric Vrignaud Hisham Megahed Jean-Pierre Cartron Cecile Masson Samer Wehbi Berengere Koehl Marie Hully Karine Siquier Nicole Chemaly Agnes Rotig Stanislas Lyonnet Yves Colin Giulia Barcia Vincent Cantagrel Caroline Le Van Kim Olivier Hermine Taroh Kinoshita Thierry Peyrard Slim Azouzi

  • Publication date : 07 February 2019 More

    Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.
    Am J Hum Genet.

    Autors : Mirmiran Arienne Martin-Schmitt Caroline Lefebvre Thibaud Manceau Hana Daher Raed Oustric V Poli A Lacapère JJ Moulouel Boualem Puy Hervé Peoch'h Katell Lenglet H Simonin S Deybach Jean-Charles Nicolas Gaël Gouya Laurent

  • Publication date : 01 July 2018 More

    Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver.
    J Intern Med.

    Autors : Martin-Schmitt Caroline Lenglet H Yu A Delaby C Benecke A Lefebvre Thibaud Letteron Philippe Paradis Valérie Wahlin S Sandberg S Harper P Sardh E Sandvik AK Hov JR Aarsand AK Chiche L Bazille C Scoazec JY To-Figueras J Carrascal M Abian J Mirmiran Arienne Deybach Jean-Charles Puy Hervé Peoch'h Katell Manceau Hana Gouya Laurent

  • Publication date : 01 April 2018 More

    Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease.

    Autors : Lefebvre Thibaud Reihani N Daher Raed de Villemeur TB Belmatoug N Rose C Colin-Aronovicz Y Puy Hervé Le Van Kim C Franco M

  • Publication date : 19 September 2017 More

    Mutation in human CLPX elevates levels of δ-aminolevulinate synthase and protoporphyrin IX to promote erythropoietic protoporphyria.
    Proc Natl Acad Sci U S A

    Autors : Yien YY Ducamp S Van der Vorm LN Kardon JR Manceau Hana Kannengiesser Caroline Bergonia HA Kafina MD Gouya Laurent Baker TA Puy Hervé Phillips JD Nicolas Gaël Paw BH

  • Publication date : 02 March 2017 More

    Gene Therapy in a Patient with Sickle Cell Disease.
    N Engl J Med.

    Autors : Ribeil JA Hacein-Bey-Abina S Payen E Magnani A Semeraro M Magrin E Caccavelli L Neven B Bourget P El Nemer W Bartolucci P Weber L Puy Hervé Meritet JF Grevent D Beuzard Y Chrétien S Lefebvre Thibaud Ross RW Negre O Veres G Sandler L Soni S De Montalembert M Blanche S Leboulch P Cavazzana M

  • Publication date : 01 March 2016 More

    Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans.

    Autors : Daher Raed Kannengiesser Caroline Houamel D Lefebvre Thibaud Bardou-Jacquet E Ducrot Nicolas De Kerguenec C Jouanolle AM Robreau AM Oudin C Le Gac C Moulouel Boualem Loustaud-Ratti V Bedossa Pierre Valla Dominique Gouya Laurent Beaumont Carole Brissot P Puy Hervé Tchernitchko Dimitri

  • Publication date : 01 March 2016 More

    Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coli.
    J Am Soc Nephrol

    Autors : Houamel D Ducrot Nicolas Lefebvre Thibaud Daher Raed Moulouel Boualem Sari MA Letteron Philippe Lyoumi Said Millot Sarah Tourret J Bouvet O Vaulont S Vandewalle A Denamur E Puy Hervé Beaumont Carole Gouya Laurent


Site de référence pour les Appels à Projets

Les dernières publications marquantes

  • Publication date : 17 January 2023 More

    ROCK2 interacts with p22phox to phosphorylate p47phox and to control NADPH oxidase activation in human monocytes

    Autors : Asma Tlili Pintard Coralie Hurtado-Nedelec Maria Margarita Liu Dan Viviana Marzaioli Thieblemont Nathalie Dang Pham My-Chan El Benna Jamel

  • Publication date : 30 November 2022 More

    Comparative Analysis of a Locally Resampling MR Elastography Reconstruction Algorithm in Liver Fibrosis

    Autors : Page Gwenael JULEA Felicia Paradis Valérie Vilgrain Valérie Valla Dominique Van Beers Bernard Garteiser Philippe

  • Publication date : 03 November 2022 More

    JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm
    Nature Communications.

    Autors : Rida Al-Rifai Marie Vandestienne Jean-Rémi Lavillegrand Tristan Mirault Julie Cornebise Poisson Johanne Ludivine Laurans Bruno Esposito Chloé James Olivier Mansier Pierre Hirsch Fabrizia Favale Rayan Braik Camille Knosp Jose Vilar Giuseppe Rizzo Alma Zernecke Antoine-Emmanuel Saliba Alain Tedgui Maxime Lacroix Lionel Arrive Ziad Mallat Soraya Taleb Marc Diedisheim Clément Cochain Rautou Pierre-Emmanuel Hafid Ait-Oufella